Dividend beasts: Experts name 3 ASX dividend shares that could deliver 50% returns next year

Brokers think that these income stocks are undervalued.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Baby Bunting continues to see sales grow and it’s expected to see margins improve over the rest of FY23
  • Nine Entertainment is still seeing a good advertising market and expects to do better than the wider industry in FY23
  • PeopleIn expects to grow its underlying EBITDA to grow in FY23, while demonstrating resilience

A number of ASX dividend shares have seen their share prices hit by volatility in 2022. But, an exciting part of the declines we're seeing is that potential dividend yields are getting pushed higher for prospective investors.

Businesses that are both undervalued and could pay a good dividend may be able to give investors an attractive total return, with a mix of both income and capital growth.

Keep in mind that just because an expert thinks a share price will rise doesn't mean the market will push it higher over the next 12 months. But I think it's interesting to look at businesses that are seen as significantly cheaper than their fair value.

With that in mind, let's look at some of the dividend opportunities that brokers think are attractive.

A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.

Image source: Getty Images

Baby Bunting Group Ltd (ASX: BBN)

The Baby Bunting share price recently got walloped. It's down around 35% since 6 October 2022. While the baby product retailing business reported total sales growth of 12% to 7 October 2022, it said the first quarter gross profit margin was down 230 basis points year over year. At the same time, pro forma net profit after tax (NPAT) in the first quarter was down $3 million year over year.

After seeing the update, the brokers at Macquarie still rate the company as an outperform, with a price target of $4.95. That implies a possible rise of around 80% over the next year. It thinks the gross profit margin can somewhat recover during the year.

The ASX dividend share plans to open eight new stores in FY23, with six in Australia and the other two in New Zealand.

Macquarie puts the Baby Bunting share price valuation at 15 times FY23's estimated earnings with a projected grossed-up dividend yield of 6.1%.

Nine Entertainment Co Holdings Ltd (ASX: NEC)

Nine is the business behind a number of media names including the Nine free-to-air television network, digital streaming business Stan, and newspapers like the Australian Financial Review, The Age, and the Sydney Morning Herald.

Since the beginning of the year, the Nine share price has dropped around 33%. That's despite the business achieving a strong level of growth in FY22. The last financial year saw revenue growth of 15% to $2.69 billion and NPAT growth of 35% to $373.5 million.

The company also said the new financial year had "started on a positive note in terms of audiences" across all of its platforms. The advertising market, to August, had also "remained resilient", Nine said. It's also expecting its advertising revenue to grow more strongly than the markets where it operates in FY23.

The ASX dividend share is currently rated as a buy by the broker Credit Suisse, with a price target of $3.30. That implies a possible rise of more than 60%. The broker predicts the FY23 grossed-up dividend yield to be 10.1%.

PeopleIn Ltd (ASX: PPE)

The business provides staff, business services, and operational services, including workforce management, recruiting, onboarding, contracting, rostering, timesheet management, payroll, and workplace health and safety management.

The PeopleIn share price is another that has suffered heavily in 2022. It is down by 33% year to date.

Broker Morgans thinks that FY23 looks good for the company, rating it as add. It has a price target of $4.90, implying a possible rise of more than 60% over the next year. The potential grossed-up dividend yield for the 2023 financial year is 7.2%.

In FY22, the ASX dividend share generated $47.2 million of normalised earnings before interest, tax, depreciation, and amortisation (EBITDA). In FY23, it guided that it could generate normalised EBITDA of between $62 million to $66 million. However, management said at the time this was "based on the continuation of current economic conditions".

However, management also said the core business is "resilient even in the event of economic uncertainty". It plans to focus on growing in sectors that are defensive and have long-term demand for talent.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Peoplein. The Motley Fool Australia has recommended Baby Bunting and Peoplein. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A happy person clenching fists in celebration sitting at computer.
Broker Notes

Morgans says hold BHP shares and buy this ASX 200 stock      

Let's see what the broker is saying about these stocks this week.

Read more »

An ASX 200 market analyst holds his hand to his chin and looks closely at his computer screens watching share price movements
Broker Notes

3 ASX 200 shares just upgraded to strong buy — here's what the brokers are saying

Do any of these ASX 200 stocks appeal to you?

Read more »

Person pressing the buy button on a smartphone.
Broker Notes

3 reasons to buy Pro Medicus shares today

A leading analyst believes Pro Medicus shares are now trading at a significant discount.

Read more »

Two men look excited on the trading floor as they hold telephones to their ears and one points upwards.
Broker Notes

Buy, hold, sell: Sigma Healthcare, Macquarie, Santos shares

Brokers reveal their latest ratings and reviews on 3 ASX 200 stocks.

Read more »

A man rests his chin in his hands, pondering what is the answer?
Broker Notes

Buy, hold, sell: Macquarie, Boss Energy, CBA shares

The market looks set to endure a sixth consecutive day in the red.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Broker Notes

Guess which ASX 200 share could rise 90% according to Bell Potter

Let's see what the broker is saying about this stock this week.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Broker Notes

These ASX 200 shares could rise 25% to 70%

Morgans expects big returns from these top stocks.

Read more »

ASX 200 shares broker downgrade origami paper fortune teller with buy hold sell and dollar sign options
Broker Notes

Down 42% in a year, are Boss Energy shares now a bargain buy?

A leading analyst provides his outlook for Boss Energy’s beaten down shares.

Read more »